Company intelligence / Profile preview

Endourage

Ownership: Private
Development stage: Other

Overview

Endourage develops novel hemp-derived therapeutics for chronic diseases through rigorous scientific validation. The company collaborates with clinicians for case studies and clinical trials but has not published specific late-stage clinical results as of now.

Therapeutic areas: Other
Modalities: Small molecule (hemp-derived compounds and formulations)Natural product therapy (hemp/cannabinoid-based)
Industry: Biotech

Drug pipeline

2 assets

Formula AX

Unknown

1 more asset in the full pipeline.

Partnerships

Collaborations with practicing clinicians and researchers for development and clinical use of products

Beyond the preview

Go deeper on Endourage.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endourage.